NCT07382726 2026-02-20Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A TrialM.D. Anderson Cancer CenterPhase 1 Not yet recruiting18 enrolled
NCT07288034 2025-12-17Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialCity of Hope Medical CenterPhase 2 Not yet recruiting535 enrolled